[{"id":"cms7izu66axcfkh0cdktjf0rw","channel":"knowledge","topic":"clinical-trials","title":"Dose-response Effects of Dietary Nitrate on Running Time-to-exhaustion and Neuromuscular Fatigue: a Randomized Crossover Exploratory Pilot Study","summary":"COMPLETED · NA · Health Adult Subjects","payload":{"url":"https://clinicaltrials.gov/study/NCT07735455","title":"Dose-response Effects of Dietary Nitrate on Running Time-to-exhaustion and Neuromuscular Fatigue: a Randomized Crossover Exploratory Pilot Study","nct_id":"NCT07735455","phases":["NA"],"source":"clinicaltrials.gov","status":"COMPLETED","conditions":["Health Adult Subjects"],"enrollment":9,"study_type":"INTERVENTIONAL","lead_sponsor":"Universidad Autonoma de Madrid","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Dietary Nitrate","type":"DIETARY_SUPPLEMENT"},{"name":"Placebo","type":"OTHER"}],"sponsor_class":"OTHER","official_title":"Dose-response Effects of Dietary Nitrate on Running Time-to-exhaustion and Neuromuscular Fatigue: a Randomized Crossover Exploratory Pilot Study","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:43.903Z"},{"id":"cms7iztntaxcdkh0c5pcnoojr","channel":"knowledge","topic":"clinical-trials","title":"Sensory Stimulation as a Driver of Diet-induced Thermogenesis","summary":"RECRUITING · NA · Diet-induced Thermogenesis","payload":{"url":"https://clinicaltrials.gov/study/NCT07409025","title":"Sensory Stimulation as a Driver of Diet-induced Thermogenesis","nct_id":"NCT07409025","phases":["NA"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Diet-induced Thermogenesis","Sensory Function"],"enrollment":24,"study_type":"INTERVENTIONAL","lead_sponsor":"University Hospital, Basel, Switzerland","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"sensory exposure","type":"PROCEDURE"},{"name":"sensory deprivation","type":"PROCEDURE"}],"sponsor_class":"OTHER","official_title":"SEnsory stimulatioN aS A Driver of dieT-induced Thermogenesis - the SENSATION Trial","first_posted_at":"2026-02-13T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:43.241Z"},{"id":"cms7izt5caxcbkh0cm6eo53tj","channel":"knowledge","topic":"clinical-trials","title":"Evaluation of a Couple-based Psycho-socio-educational Intervention Using WeChat/WhatsApp on Dyadic Psychological and Sleep Outcomes","summary":"NOT_YET_RECRUITING · NA · Sleep Problems","payload":{"url":"https://clinicaltrials.gov/study/NCT07736378","title":"Evaluation of a Couple-based Psycho-socio-educational Intervention Using WeChat/WhatsApp on Dyadic Psychological and Sleep Outcomes","nct_id":"NCT07736378","phases":["NA"],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Sleep Problems","Psychological","Well-Being, Psychological"],"enrollment":336,"study_type":"INTERVENTIONAL","lead_sponsor":"Chinese University of Hong Kong","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Couple-based psycho-socio-educational intervention using WeChat/WhatsApp","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Evaluation of a Couple-based Psycho-socio-educational Intervention Using WeChat/WhatsApp on Dyadic Psychological and Sleep Outcomes: A 3-armed Randomised Controlled Trial","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:42.577Z"},{"id":"cms7izsn2axc9kh0cqgyu09xb","channel":"knowledge","topic":"clinical-trials","title":"Self Help Program for Hypnotics Withdrawal in Insomniac Patients","summary":"TERMINATED · NA · Insomnia","payload":{"url":"https://clinicaltrials.gov/study/NCT02720458","title":"Self Help Program for Hypnotics Withdrawal in Insomniac Patients","nct_id":"NCT02720458","phases":["NA"],"source":"clinicaltrials.gov","status":"TERMINATED","conditions":["Insomnia"],"enrollment":62,"study_type":"INTERVENTIONAL","lead_sponsor":"University Hospital, Bordeaux","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Standardized gradual hypnotic taper","type":"OTHER"},{"name":"Short-term simple self-help program","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Self-help Program for Hypnotics Withdrawal in Chronic Insomniac Patients: A Randomized Controlled Clinical Trial","first_posted_at":"2016-03-28T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:41.919Z"},{"id":"cms7izs4waxc7kh0cmrna6t3g","channel":"knowledge","topic":"clinical-trials","title":"Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease","summary":"NOT_YET_RECRUITING · Inflammatory Bowel Disease","payload":{"url":"https://clinicaltrials.gov/study/NCT07619547","title":"Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease","nct_id":"NCT07619547","phases":[],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Inflammatory Bowel Disease","Crohn's Disease","Ulcerative Colitis"],"enrollment":100,"study_type":"OBSERVATIONAL","lead_sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","published_at":"2026-07-30T00:00:00.000Z","interventions":[],"sponsor_class":"NIH","official_title":"Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease","first_posted_at":"2026-06-02T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:41.264Z"},{"id":"cms7izrmjaxc5kh0ceoeu2fin","channel":"knowledge","topic":"clinical-trials","title":"A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours","summary":"RECRUITING · PHASE1/PHASE2 · Advanced Solid Tumor","payload":{"url":"https://clinicaltrials.gov/study/NCT06833008","title":"A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours","nct_id":"NCT06833008","phases":["PHASE1","PHASE2"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Advanced Solid Tumor"],"enrollment":85,"study_type":"INTERVENTIONAL","lead_sponsor":"Ipsen","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"IPN01195","type":"DRUG"}],"sponsor_class":"INDUSTRY","official_title":"An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours","first_posted_at":"2025-02-18T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:40.604Z"},{"id":"cms7izr4baxc3kh0c3ss3fx6z","channel":"knowledge","topic":"clinical-trials","title":"How Much Virtual Reality Intervention Improve the Balance of Patients With Cerebral Palsy","summary":"RECRUITING · NA · Cerebral Palsy","payload":{"url":"https://clinicaltrials.gov/study/NCT06769178","title":"How Much Virtual Reality Intervention Improve the Balance of Patients With Cerebral Palsy","nct_id":"NCT06769178","phases":["NA"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Cerebral Palsy"],"enrollment":24,"study_type":"INTERVENTIONAL","lead_sponsor":"Yeditepe University","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Virtual Reality based","type":"OTHER"}],"sponsor_class":"OTHER","official_title":"Effect of Virtual Reality-Based Interventions on Clinical and Neuroplasticity, Brain Functional Resting State Networks in Cerebral Palsy Rehabilitation","first_posted_at":"2025-01-10T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:39.947Z"},{"id":"cms7izqlvaxc1kh0ckr0smrmk","channel":"knowledge","topic":"clinical-trials","title":"A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma","summary":"ACTIVE_NOT_RECRUITING · PHASE3 · Alveolar Rhabdomyosarcoma","payload":{"url":"https://clinicaltrials.gov/study/NCT04994132","title":"A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma","nct_id":"NCT04994132","phases":["PHASE3"],"source":"clinicaltrials.gov","status":"ACTIVE_NOT_RECRUITING","conditions":["Alveolar Rhabdomyosarcoma","Botryoid-Type Embryonal Rhabdomyosarcoma","Embryonal Rhabdomyosarcoma","Metastatic Embryonal Rhabdomyosarcoma","Metastatic Rhabdomyosarcoma","Solid Alveolar Rhabdomyosarcoma","Spindle Cell Rhabdomyosarcoma","Spindle Cell/Sclerosing Rhabdomyosarcoma"],"enrollment":113,"study_type":"INTERVENTIONAL","lead_sponsor":"Children's Oncology Group","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Biospecimen Collection","type":"PROCEDURE"},{"name":"Bone Marrow Aspiration","type":"PROCEDURE"},{"name":"Bone Marrow Biopsy","type":"PROCEDURE"},{"name":"Bone Scan","type":"PROCEDURE"},{"name":"Computed Tomography","type":"PROCEDURE"},{"name":"Cyclophosphamide","type":"DRUG"},{"name":"Dactinomycin","type":"BIOLOGICAL"},{"name":"Magnetic Resonance Imaging","type":"PROCEDURE"},{"name":"Positron Emission Tomography","type":"PROCEDURE"},{"name":"Radiation Therapy","type":"RADIATION"}],"sponsor_class":"NETWORK","official_title":"A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy With Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) Plus VINO-CPO Maintenance in Patients With High Risk Rhabdomyosarcoma (HR-RMS)","first_posted_at":"2021-08-06T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:39.284Z"},{"id":"cms7izq3caxbzkh0cdqdhsq1p","channel":"knowledge","topic":"clinical-trials","title":"Effects of Core Stabilization Exercises on Postural Control in Spastic Diplegic CP Children: a Randomized Control Trial","summary":"NOT_YET_RECRUITING · NA · Spastic Diplegic Cerebral Palsy","payload":{"url":"https://clinicaltrials.gov/study/NCT07736417","title":"Effects of Core Stabilization Exercises on Postural Control in Spastic Diplegic CP Children: a Randomized Control Trial","nct_id":"NCT07736417","phases":["NA"],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Spastic Diplegic Cerebral Palsy"],"enrollment":60,"study_type":"INTERVENTIONAL","lead_sponsor":"Shifa Tameer-e-Millat University","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Exercise","type":"OTHER"},{"name":"Conventional","type":"OTHER"}],"sponsor_class":"OTHER","official_title":"Effects of Core Stabilization Exercises on Postural Control in Spastic Diplegic CP Children: a Randomized Control Trial","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:38.617Z"},{"id":"cms7izpkxaxbxkh0clxg1tpg0","channel":"knowledge","topic":"clinical-trials","title":"MIBG in Aging and Neurologic Disorders","summary":"ENROLLING_BY_INVITATION · PHASE4 · Lewy Body Disease","payload":{"url":"https://clinicaltrials.gov/study/NCT05514106","title":"MIBG in Aging and Neurologic Disorders","nct_id":"NCT05514106","phases":["PHASE4"],"source":"clinicaltrials.gov","status":"ENROLLING_BY_INVITATION","conditions":["Lewy Body Disease","Dementia","Parkinsonism","Mild Cognitive Impairment","REM Sleep Behavior Disorder"],"enrollment":50,"study_type":"INTERVENTIONAL","lead_sponsor":"Mayo Clinic","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"meta-iodobenzylguanidine (MIBG) (123I)","type":"DRUG"},{"name":"123I-MIBG scintigraphy","type":"DIAGNOSTIC_TEST"}],"sponsor_class":"OTHER","official_title":"Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease","first_posted_at":"2022-08-24T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:37.954Z"},{"id":"cms7izp2gaxbvkh0czjhaox56","channel":"knowledge","topic":"clinical-trials","title":"A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases","summary":"RECRUITING · PHASE2 · Systemic Lupus Erythematosus","payload":{"url":"https://clinicaltrials.gov/study/NCT06570798","title":"A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases","nct_id":"NCT06570798","phases":["PHASE2"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Systemic Lupus Erythematosus","Active Refractory Rheumatoid Arthritis"],"enrollment":220,"study_type":"INTERVENTIONAL","lead_sponsor":"Amgen","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Inebilizumab","type":"DRUG"},{"name":"Blinatumomab","type":"DRUG"}],"sponsor_class":"INDUSTRY","official_title":"A Phase 2, Open Label, Multicenter, Platform Trial to Assess the Safety, Tolerability, and Efficacy of Inebilizumab and Blinatumomab in Subjects With Autoimmune Diseases","first_posted_at":"2024-08-26T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:37.289Z"},{"id":"cms7izojwaxbtkh0cj5o0y69s","channel":"knowledge","topic":"clinical-trials","title":"Artificially Intelligent Robotic Control","summary":"NOT_YET_RECRUITING · NA · Asthma in Children","payload":{"url":"https://clinicaltrials.gov/study/NCT07738016","title":"Artificially Intelligent Robotic Control","nct_id":"NCT07738016","phases":["NA"],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Asthma in Children","Artificial Intelligence","Caregiver Burden"],"enrollment":80,"study_type":"INTERVENTIONAL","lead_sponsor":"University of Miami","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Artificially Intelligent Robot (AIR) Control Intervention","type":"BEHAVIORAL"},{"name":"Standard Asthma Education","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Asthma Under Artificially Intelligent Robotic (AIR) Control: Robotic Support for Pediatric Education","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:36.620Z"},{"id":"cms7izo1jaxbrkh0cdhky2761","channel":"knowledge","topic":"clinical-trials","title":"Tumor-Derived FGF19","summary":"COMPLETED · Colorectal Cancer","payload":{"url":"https://clinicaltrials.gov/study/NCT06068257","title":"Tumor-Derived FGF19","nct_id":"NCT06068257","phases":[],"source":"clinicaltrials.gov","status":"COMPLETED","conditions":["Colorectal Cancer","Breast Cancer","Healthy"],"enrollment":119,"study_type":"OBSERVATIONAL","lead_sponsor":"University of Central Florida","published_at":"2026-07-30T00:00:00.000Z","interventions":[],"sponsor_class":"OTHER","official_title":"Translational Utility of Tumor-Derived FGF19 in a Novel Blood-Based Endocrine Suppression Approach","first_posted_at":"2023-10-05T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:35.960Z"},{"id":"cms7iznj4axbpkh0c7ef7a5vs","channel":"knowledge","topic":"clinical-trials","title":"B4B Evolution Type II Hybrid Effectiveness-Implementation Trial","summary":"ENROLLING_BY_INVITATION · NA · Physical Activity","payload":{"url":"https://clinicaltrials.gov/study/NCT07726732","title":"B4B Evolution Type II Hybrid Effectiveness-Implementation Trial","nct_id":"NCT07726732","phases":["NA"],"source":"clinicaltrials.gov","status":"ENROLLING_BY_INVITATION","conditions":["Physical Activity","Sedentary Behavior","Cognition","Academic Acheivement"],"enrollment":300,"study_type":"INTERVENTIONAL","lead_sponsor":"University of the Balearic Islands","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Break4Brain Evolution","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Classroom Movement Strategies to Increase Physical Activity and Improve Cognition and Academic Performance in a School-Aged Population: Protocol for the Break4Brain Type II Hybrid Effectiveness-Implementation Trial","first_posted_at":"2026-07-24T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:35.297Z"},{"id":"cms7izn08axbnkh0c0r4qlbwv","channel":"knowledge","topic":"clinical-trials","title":"Neuromodulation of the Cortex and Spinal Cord","summary":"ACTIVE_NOT_RECRUITING · NA · Cerebral Palsy","payload":{"url":"https://clinicaltrials.gov/study/NCT06586437","title":"Neuromodulation of the Cortex and Spinal Cord","nct_id":"NCT06586437","phases":["NA"],"source":"clinicaltrials.gov","status":"ACTIVE_NOT_RECRUITING","conditions":["Cerebral Palsy"],"enrollment":50,"study_type":"INTERVENTIONAL","lead_sponsor":"Father Flanagan's Boys' Home","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Clinical Assessments","type":"BEHAVIORAL"},{"name":"Brain-Spinal Cord fMRI","type":"BEHAVIORAL"},{"name":"Hoffmann Reflex Assessments","type":"BEHAVIORAL"},{"name":"MEG Imaging","type":"BEHAVIORAL"},{"name":"Transcutaneous Current Stimulation","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Neuromodulation of the Cortex and Spinal Cord","first_posted_at":"2024-09-19T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:34.616Z"},{"id":"cms7izmhuaxblkh0cgtz62slb","channel":"knowledge","topic":"clinical-trials","title":"Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.","summary":"RECRUITING · PHASE3 · GLP-1","payload":{"url":"https://clinicaltrials.gov/study/NCT07736911","title":"Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.","nct_id":"NCT07736911","phases":["PHASE3"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["GLP-1"],"enrollment":140,"study_type":"INTERVENTIONAL","lead_sponsor":"Fu Jen Catholic University Hospital","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Stop for 1 week","type":"DRUG"},{"name":"GLP-1 non stop","type":"DRUG"}],"sponsor_class":"OTHER","official_title":"Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy: A Randomized Controlled Trial.","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:33.954Z"},{"id":"cms7izlzfaxbjkh0c1h6m1l39","channel":"knowledge","topic":"clinical-trials","title":"Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)","summary":"NOT_YET_RECRUITING · NA · Lung; Node","payload":{"url":"https://clinicaltrials.gov/study/NCT07735611","title":"Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)","nct_id":"NCT07735611","phases":["NA"],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Lung; Node"],"enrollment":398,"study_type":"INTERVENTIONAL","lead_sponsor":"Case Comprehensive Cancer Center","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"RAB via the Monarch platform","type":"PROCEDURE"},{"name":"RAB via the ION platform","type":"PROCEDURE"}],"sponsor_class":"OTHER","official_title":"Robotic Systems Evaluation for Peripheral Pulmonary Lesions: A Randomized Trial (RISE Trial)","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:33.291Z"},{"id":"cms7izlgyaxbhkh0c8gin1xhe","channel":"knowledge","topic":"clinical-trials","title":"Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery","summary":"ACTIVE_NOT_RECRUITING · PHASE3 · Clinical Stage III Cutaneous Melanoma AJCC v8","payload":{"url":"https://clinicaltrials.gov/study/NCT02506153","title":"Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery","nct_id":"NCT02506153","phases":["PHASE3"],"source":"clinicaltrials.gov","status":"ACTIVE_NOT_RECRUITING","conditions":["Clinical Stage III Cutaneous Melanoma AJCC v8","Clinical Stage IV Cutaneous Melanoma AJCC v8","Metastatic Cutaneous Melanoma","Metastatic Mucosal Melanoma","Metastatic Non-Cutaneous Melanoma","Non-Cutaneous Melanoma","Recurrent Cutaneous Melanoma","Recurrent Mucosal Melanoma","Recurrent Non-Cutaneous Melanoma"],"enrollment":1301,"study_type":"INTERVENTIONAL","lead_sponsor":"National Cancer Institute (NCI)","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Biospecimen Collection","type":"PROCEDURE"},{"name":"Computed Tomography","type":"PROCEDURE"},{"name":"Ipilimumab","type":"BIOLOGICAL"},{"name":"Magnetic Resonance Imaging","type":"PROCEDURE"},{"name":"Pembrolizumab","type":"BIOLOGICAL"},{"name":"Positron Emission Tomography","type":"PROCEDURE"},{"name":"Quality-of-Life Assessment","type":"OTHER"},{"name":"Recombinant Interferon Alfa-2b","type":"BIOLOGICAL"}],"sponsor_class":"NIH","official_title":"A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma","first_posted_at":"2015-07-23T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:32.626Z"},{"id":"cms7izky9axbfkh0c3hof99ok","channel":"knowledge","topic":"clinical-trials","title":"Work And Vocational advicE Study - Effectiveness of Adding a Brief Vocational Support Intervention to Usual Primary Care","summary":"TERMINATED · NA · Musculoskeletal Pain","payload":{"url":"https://clinicaltrials.gov/study/NCT04543097","title":"Work And Vocational advicE Study - Effectiveness of Adding a Brief Vocational Support Intervention to Usual Primary Care","nct_id":"NCT04543097","phases":["NA"],"source":"clinicaltrials.gov","status":"TERMINATED","conditions":["Musculoskeletal Pain","Mental Health Issue","Mental Health Disorder","Other Physical Health Condition","Absence"],"enrollment":130,"study_type":"INTERVENTIONAL","lead_sponsor":"Keele University","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Vocational Support","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Work And Vocational advicE (WAVE) in Primary Care: a Randomised Controlled Trial","first_posted_at":"2020-09-09T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:31.954Z"},{"id":"cms7izk9kaxbbkh0c4yn6y8nx","channel":"knowledge","topic":"clinical-trials","title":"Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair","summary":"ACTIVE_NOT_RECRUITING · PHASE3 · Colon Adenocarcinoma","payload":{"url":"https://clinicaltrials.gov/study/NCT02912559","title":"Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair","nct_id":"NCT02912559","phases":["PHASE3"],"source":"clinicaltrials.gov","status":"ACTIVE_NOT_RECRUITING","conditions":["Colon Adenocarcinoma","DNA Repair Disorder","Lynch Syndrome","Stage III Colon Cancer AJCC v8"],"enrollment":712,"study_type":"INTERVENTIONAL","lead_sponsor":"National Cancer Institute (NCI)","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Atezolizumab","type":"DRUG"},{"name":"Biospecimen Collection","type":"PROCEDURE"},{"name":"Computed Tomography","type":"PROCEDURE"},{"name":"Fluorouracil","type":"DRUG"},{"name":"Leucovorin Calcium","type":"DRUG"},{"name":"Magnetic Resonance Imaging","type":"PROCEDURE"},{"name":"Oxaliplatin","type":"DRUG"},{"name":"Quality-of-Life Assessment","type":"OTHER"}],"sponsor_class":"NIH","official_title":"Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair","first_posted_at":"2016-09-23T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:31.064Z"},{"id":"cms7izjrcaxb9kh0c3tsiqw1t","channel":"knowledge","topic":"clinical-trials","title":"Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.","summary":"NOT_YET_RECRUITING · NA · Intrabony Periodontal Defect","payload":{"url":"https://clinicaltrials.gov/study/NCT07737834","title":"Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.","nct_id":"NCT07737834","phases":["NA"],"source":"clinicaltrials.gov","status":"NOT_YET_RECRUITING","conditions":["Intrabony Periodontal Defect"],"enrollment":30,"study_type":"INTERVENTIONAL","lead_sponsor":"Medical University of Warsaw","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Entire Papilla Preservation Technique (EPPT)","type":"PROCEDURE"},{"name":"EDTA root conditioning","type":"OTHER"},{"name":"Enamel Matrix Derivative (EMD)- Emdogain","type":"DRUG"},{"name":"Subepithelial Connective Tissue Graft (SCTG)","type":"PROCEDURE"},{"name":"Bone substitute - Bio Oss Collagen","type":"OTHER"}],"sponsor_class":"OTHER","official_title":"Clinical, Radiographic and Volumetric Evaluation of the Entire Papilla Preservation Technique With and Without Connective Tissue Graft in the Treatment of Periodontal Intraosseous Defects.","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:30.408Z"},{"id":"cms7izj93axb7kh0cpowy30zs","channel":"knowledge","topic":"clinical-trials","title":"Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)","summary":"RECRUITING · NA · Type 2 Diabetes","payload":{"url":"https://clinicaltrials.gov/study/NCT07032844","title":"Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)","nct_id":"NCT07032844","phases":["NA"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Type 2 Diabetes"],"enrollment":5000,"study_type":"INTERVENTIONAL","lead_sponsor":"University of Alabama at Birmingham","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Digital Health Coaching","type":"BEHAVIORAL"},{"name":"Continuous Glucose Monitoring Teleconsults","type":"BEHAVIORAL"},{"name":"Continuous Glucose Monitoring Teleconsults + Digital Health Coaching","type":"BEHAVIORAL"}],"sponsor_class":"OTHER","official_title":"Comparing the Effectiveness of Primary Care Delivered Telehealth Interventions to Manage Type 2 Diabetes in People With Physical Disabilities and Multiple Chronic Conditions","first_posted_at":"2025-06-24T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:29.751Z"},{"id":"cms7iziqtaxb5kh0cayixpzw8","channel":"knowledge","topic":"clinical-trials","title":"Ruscus Evaluation for Symptom Control in Uncomplicated Chronic Venous Insufficiency","summary":"RECRUITING · Chronic Venous Disease","payload":{"url":"https://clinicaltrials.gov/study/NCT07737236","title":"Ruscus Evaluation for Symptom Control in Uncomplicated Chronic Venous Insufficiency","nct_id":"NCT07737236","phases":[],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Chronic Venous Disease"],"enrollment":564,"study_type":"OBSERVATIONAL","lead_sponsor":"Turkish Society for Vascular and Endovascular Surgery","published_at":"2026-07-30T00:00:00.000Z","interventions":[],"sponsor_class":"OTHER","official_title":"Evaluation of the Effects of Ruscus Aculeatus L. on Clinical Course and Quality of Life, and Assessment of Treatment Adherence and Tolerability in the Treatment of Chronic Venous Insufficiency: A Multicenter, Prospective, Observational Study","first_posted_at":"2026-07-30T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:29.093Z"},{"id":"cms7izi8eaxb3kh0cbziihaql","channel":"knowledge","topic":"clinical-trials","title":"Chinese Medicine for Treating Chronic Pharyngolaryngitis","summary":"RECRUITING · PHASE2 · Chronic Pharyngolaryngitis (Disorder)","payload":{"url":"https://clinicaltrials.gov/study/NCT05665777","title":"Chinese Medicine for Treating Chronic Pharyngolaryngitis","nct_id":"NCT05665777","phases":["PHASE2"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["Chronic Pharyngolaryngitis (Disorder)"],"enrollment":74,"study_type":"INTERVENTIONAL","lead_sponsor":"Chinese University of Hong Kong","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Qingyan Lihou Decoction","type":"DRUG"},{"name":"Placebo","type":"OTHER"}],"sponsor_class":"OTHER","official_title":"The Effectiveness and Safety of Qingyan Lihou Decoction for the Treatment of Chronic Pharyngolaryngitis: A Randomized, Double-blinded, Placebo-controlled Trial","first_posted_at":"2022-12-27T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:28.430Z"},{"id":"cms7izhq2axb1kh0ciqhksgkn","channel":"knowledge","topic":"clinical-trials","title":"Colchicine Use in Intracranial Atherosclerotic Disease","summary":"RECRUITING · PHASE2 · ICAD - Intracranial Atherosclerotic Disease","payload":{"url":"https://clinicaltrials.gov/study/NCT05503225","title":"Colchicine Use in Intracranial Atherosclerotic Disease","nct_id":"NCT05503225","phases":["PHASE2"],"source":"clinicaltrials.gov","status":"RECRUITING","conditions":["ICAD - Intracranial Atherosclerotic Disease"],"enrollment":72,"study_type":"INTERVENTIONAL","lead_sponsor":"Chinese University of Hong Kong","published_at":"2026-07-30T00:00:00.000Z","interventions":[{"name":"Colchicine 0.5 MG","type":"DRUG"}],"sponsor_class":"OTHER","official_title":"Colchicine Use in Intracranial Atherosclerotic Disease - a Pilot Open-labelled Randomized Trial","first_posted_at":"2022-08-16T00:00:00.000Z"},"public_metadata":null,"published_at":"2026-07-30T13:04:27.770Z"}]